ArticleAsian Pacific journal of cancer prevention : APJCP2021

Effectiveness and Tolerability of First-Line Afatinib for Advanced EGFR-Mutant Non-Small Cell Lung Cancer in Vietnam.

Thanh Ha Vu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.